Articles related to MEDICAL CONTROVERSY

The study’s findings suggest that industry payments to oncologists could potentially influence treatment decisions, leading to the prescription of nonrecommended or low-value treatments. This raises important questions about the potential impacts of these payments on patient care.

Despite the potential benefits of ketamine in treating a range of neurological and psychiatric disorders, the FDA has issued warnings about the potential risks associated with its use, emphasizing the need for careful prescription and clinical oversight.

The recent suspension of Dr. Benjamin Neel, former director of NYU’s Perlmutter Cancer Center, underscores the importance of academic integrity in the medical field. As healthcare professionals, it’s crucial to uphold the highest standards of conduct in our research.

The FDA’s approval of brexpiprazole for Alzheimer’s-related agitation has sparked a debate over its efficacy and safety, raising concerns that extend beyond this specific drug to the integrity of the regulatory process itself.

AI-driven opioid monitoring systems are increasingly influencing medical decisions, but questions about their accuracy and potential bias persist. Learn how these tools could impact your practice and patient care.

Dr. Harvey Risch’s recent claims linking COVID-19 vaccines to increased rates of certain cancers are raising eyebrows within the medical community. Learn more about the controversial assertions and their current standing in scientific scrutiny.